DXYN stock was delisted from NASDAQ on
Oct 2, 2024. You can explore more stocks from
Consumer Cyclical sector on this page.
Have a feature idea you'd love to see implemented?
Let us know!
EPIX Essa Pharma Inc
Price (delayed)
$5.31
Market cap
$235.6M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.62
Enterprise value
$149.7M
as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in
Highlights
The company's debt fell by 3.3% QoQ
EPIX's quick ratio is down by 18% year-on-year but it is up by 12% since the previous quarter
EPIX's equity is down by 14% year-on-year and by 3.5% since the previous quarter
Key stats
What are the main financial stats of EPIX
Market
Valuations
Earnings
Shares outstanding
44.37M
Market cap
$235.6M
Enterprise value
$149.7M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.83
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$27.67M
EBITDA
-$27.57M
Free cash flow
-$23.84M
Per share
Balance sheet
Liquidity
EPS
-$0.62
Free cash flow per share
-$0.54
Book value per share
$2.9
Revenue per share
$0
TBVPS
$2.99
Total assets
$132.67M
Total liabilities
$3.8M
Debt
$342,142
Equity
$128.86M
Working capital
$128.52M
Debt to equity
0
Current ratio
36.95
Quick ratio
36.68
Net debt/EBITDA
3.12
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-19.6%
Return on equity
-20.2%
Return on invested capital
-36.5%
Return on capital employed
-21.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EPIX stock price
How has the Essa Pharma stock price performed over time
Intraday
-7.49%
1 week
-13.24%
1 month
-17.42%
1 year
35.81%
YTD
-19.55%
QTD
-12.38%
Financial performance
How have Essa Pharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$33.88M
Net income
-$27.67M
Gross margin
N/A
Net margin
N/A
EPIX's operating income is down by 6% year-on-year
Growth
What is Essa Pharma's growth rate over time
Valuation
What is Essa Pharma stock price valuation
P/E
N/A
P/B
1.83
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The stock's price to book (P/B) is 14% less than its 5-year quarterly average of 2.3 but 4.2% more than its last 4 quarters average of 1.9
EPIX's equity is down by 14% year-on-year and by 3.5% since the previous quarter
Efficiency
How efficient is Essa Pharma business performance
EPIX's return on invested capital is down by 48% year-on-year and by 22% since the previous quarter
EPIX's ROE is down by 17% YoY and by 3.6% from the previous quarter
EPIX's return on assets is down by 15% year-on-year and by 3.2% since the previous quarter
Dividends
What is EPIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EPIX.
Financial health
How did Essa Pharma financials performed over time
The company's current ratio fell by 18% YoY but it rose by 12% QoQ
EPIX's quick ratio is down by 18% year-on-year but it is up by 12% since the previous quarter
The company's debt is 100% lower than its equity
EPIX's equity is down by 14% year-on-year and by 3.5% since the previous quarter
The company's debt fell by 3.3% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.